Submitted:
24 December 2024
Posted:
24 December 2024
You are already at the latest version
Abstract
Background: Traumatic brain injury (TBI) is a critical condition that significantly endangers hu-man health. Investigating the mechanisms underlying secondary injury in TBI can facilitate early intervention and treatment strategies. The metabolism of intracellular iron is pivotal in the sec-ondary injury process following TBI, with ferroptosis identified as a contributing factor. However, research exploring the relationship between the extent of ferroptosis and the severity of neuro-logical deficits across various TBI models is still limited. Objective: This study seeks to examine the association between ferroptosis in brain tissues and neurological impairments in TBI models with differing injury severities, thereby providing a theoretical framework for understanding the mechanisms and standardizing treatment approaches for TBI. Methods: 36 Male Sprague-Dawley rats were randomly assigned to four groups: a sham group, a mild TBI group (mTBI), a mild-moderate TBI group (mmTBI), and a severe TBI group (sTBI). A rat model of TBI with var-ying injury levels was established using the Feeney free-fall impact method. Neurological function deficits were assessed using the modified Neurological Severity Score (mNSS). Magnetic reso-nance imaging (MRI), transmission electron microscopy (TEM), and Prussian blue staining were utilized to examine iron deposition and ferroptosis in the cortical regions of the rat brains. Western blot analysis was conducted to evaluate the expression of ferroptosis-related molecular markers, and the correlation between mNSS scores and these markers was analyzed. Results: 1) MRI scans indicated that, in comparison to the sham group, the TBI groups displayed elevated signals in the T2WI and T2*WI sequences, signifying brain injury, edema, and hemorrhage. T2*WI revealed diminished signals surrounding the injured areas, indicating iron deposition. 2) TEM analysis revealed that neurons in the TBI group exhibited morphological alterations, including mitochon-drial atrophy, membrane thickening, and partial rupture of the outer membrane. 3) Prussian blue staining demonstrated a progressive increase in iron-positive cells correlating with TBI severity. 4) Western blot results indicated that the expression levels of ferroptosis-related proteins (FTH1 and GPX4) were significantly lower in the mmTBI and sTBI groups compared to the sham group. 5) MDA levels were markedly elevated in the TBI groups, and mNSS scores increased with the se-verity of injury. Correlation analysis revealed a significant negative correlation between mNSS scores and the expression of ferroptosis inhibitors FTH1 and GPX4, alongside a positive correlation with MDA levels. Conclusion: Iron deposition and ferroptosis occur in brain tissue following TBI, and they are closely linked to the severity of neurological impairment.
Keywords:
1. Introduction
2. Materials and Methods
2.1. Experimental Animals
2.2. TBI Animal Model
2.3. Experimental Groups
- Sham group
- Mild TBI group (mTBI)
- Mild-moderate TBI group (mmTBI)
- Severe TBI group (sTBI)
2.4. Magnetic Resonance Imaging (MRI)
- Coronal T2-weighted imaging (T2WI): Resolution 0.3 × 0.33 × 2 mm, Repetition Time (TR) 2000 ms, Echo Time (TE) 80 ms.
- Coronal T2* imaging (T2*WI): Resolution 0.53 × 0.53 × 2 mm, TR 510 ms, TE 16 ms, Flip Angle 18°.
2.5. Prussian Blue Staining
2.6. Transmission Electron Microscopy (TEM)
2.7. Western Blot Analysis
2.8. MDA (Malondialdehyde) Content Measurement
2.9. Statistical Analysis
3. Results
3.1. MRI Reveals Iron Accumulation in Brain Tissue Adjacent to Injury Site in TBI Rats
3.2. TEM Demonstrates Evidence of Ferroptosis in Neurons of TBI Rats
3.3. Prussian Blue Staining Indicates Iron Deposition in the Cortex of TBI Rats
3.4. Reduced Expression of Ferroptosis Negative Regulators in the Cortex Correlates with Increased Neurological Damage
3.5. Elevated Lipid Peroxidation in the Cortex Correlates with Enhanced Neurological Damage
3.6. Increased mNSS Scores Correlate with Increased Ferroptosis and Oxidative Stress
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Reddi, S.; Thakker-Varia, S.; Alder, J.; Giarratana, A.O. Status of precision medicine approaches to traumatic brain injury. Neural Regen Res 2022, 17, 2166-2171. [CrossRef]
- Martinez, B.; Peplow, P.V. Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration. Neural Regen Res 2022, 17, 2108-2116. [CrossRef]
- Scarboro, M.; McQuillan, K.A. Traumatic Brain Injury Update. AACN Adv Crit Care 2021, 32, 29-50. [CrossRef]
- Muhammad, S.A.; Abbas, A.Y.; Imam, M.U.; Saidu, Y.; Bilbis, L.S. Efficacy of stem cell secretome in the treatment of traumatic brain injury: A systematic review and meta-analysis of preclinical studies. Mol Neurobiol 2022, 59, 2894-2909. [CrossRef]
- Zhou, C.; Zheng, J.; Fan, Y.; Wu, J. TI: NLRP3 Inflammasome-Dependent Pyroptosis in CNS Trauma: A Potential Therapeutic Target. Front Cell Dev Biol 2022, 10, 821225. [CrossRef]
- Dixon, S.J.; Lemberg, K.M.; Lamprecht, M.R.; Skouta, R.; Zaitsev, E.M.; Gleason, C.E.; Patel, D.N.; Bauer, A.J.; Cantley, A.M.; Yang, W.S.; et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012, 149, 1060-1072. [CrossRef]
- Chen, D.; Fan, Z.; Rauh, M.; Buchfelder, M.; Eyupoglu, I.Y.; Savaskan, N. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene 2017, 36, 5593-5608. [CrossRef]
- Alim, I.; Caulfield, J.T.; Chen, Y.; Swarup, V.; Geschwind, D.H.; Ivanova, E.; Seravalli, J.; Ai, Y.; Sansing, L.H.; Ste Marie, E.J.; et al. Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke. Cell 2019, 177, 1262-1279.e1225. [CrossRef]
- Kenny, E.M.; Fidan, E.; Yang, Q.; Anthonymuthu, T.S.; New, L.A.; Meyer, E.A.; Wang, H.; Kochanek, P.M.; Dixon, C.E.; Kagan, V.E.; et al. Ferroptosis Contributes to Neuronal Death and Functional Outcome After Traumatic Brain Injury. Crit Care Med 2019, 47, 410-418. [CrossRef]
- Xie, B.S.; Wang, Y.Q.; Lin, Y.; Mao, Q.; Feng, J.F.; Gao, G.Y.; Jiang, J.Y. Inhibition of ferroptosis attenuates tissue damage and improves long-term outcomes after traumatic brain injury in mice. CNS Neurosci Ther 2019, 25, 465-475. [CrossRef]
- Roth, T.L.; Nayak, D.; Atanasijevic, T.; Koretsky, A.P.; Latour, L.L.; McGavern, D.B. Transcranial amelioration of inflammation and cell death after brain injury. Nature 2014, 505, 223-228. [CrossRef]
- Sulhan, S.; Lyon, K.A.; Shapiro, L.A.; Huang, J.H. Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets. J Neurosci Res 2020, 98, 19-28. [CrossRef]
- Yan, H.F.; Zou, T.; Tuo, Q.Z.; Xu, S.; Li, H.; Belaidi, A.A.; Lei, P. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther 2021, 6, 49. [CrossRef]
- Geeraerts, T.; Velly, L.; Abdennour, L.; Asehnoune, K.; Audibert, G.; Bouzat, P.; Bruder, N.; Carrillon, R.; Cottenceau, V.; Cotton, F.; et al. Management of severe traumatic brain injury (first 24hours). Anaesth Crit Care Pain Med 2018, 37, 171-186. [CrossRef]
- Yang, W.S.; Stockwell, B.R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 2008, 15, 234-245. [CrossRef]
- Gao, M.; Monian, P.; Quadri, N.; Ramasamy, R.; Jiang, X. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell 2015, 59, 298-308. [CrossRef]
- Li, J.; Cao, F.; Yin, H.L.; Huang, Z.J.; Lin, Z.T.; Mao, N.; Sun, B.; Wang, G. Ferroptosis: past, present and future. Cell Death Dis 2020, 11, 88. [CrossRef]
- Liang, D.; Feng, Y.; Zandkarimi, F.; Wang, H.; Zhang, Z.; Kim, J.; Cai, Y.; Gu, W.; Stockwell, B.R.; Jiang, X. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 2023, 186, 2748-2764.e2722. [CrossRef]
- Awasthi, D.; Church, D.F.; Torbati, D.; Carey, M.E.; Pryor, W.A. Oxidative stress following traumatic brain injury in rats. Surg Neurol 1997, 47, 575-581; discussion 581-572. [CrossRef]







| Group | MDA (nmol/mg prot) |
| sham | 0.13±0.02 |
| mTBI | 0.25±0.01 |
| mmTBI | 0.29±0.01 |
| sTBI | 0.34±0.02 |
| Group | mNSS |
| sham | 0.00±0.00 |
| mTBI | 4.67±1.15 |
| mmTBI | 10.67±0.58 |
| sTBI | 15.33±0.58 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).